Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
David A Reardon, Kai W Wucherpfennig, Gordon Freeman, Catherine J Wu, E Antonio Chiocca, Patrick Y Wen, William T Curry$suffix/text()$suffix/text(), Duane A Mitchell, Peter E Fecci, John H Sampson & Glenn Dranoff. (2013) An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Review of Vaccines 12:6, pages 597-615.
Read now
Read now
Brian M Alexander, Eudocia Q Lee, David A Reardon & Patrick Y Wen. (2013) Current and future directions for Phase II trials in high-grade glioma. Expert Review of Neurotherapeutics 13:4, pages 369-387.
Read now
Read now
David A Reardon, James R Perry, Alba A Brandes, Rakesh Jalali & Wolfgang Wick. (2011) Advances in malignant glioma drug discovery. Expert Opinion on Drug Discovery 6:7, pages 739-753.
Read now
Read now
Tobias Walbert & Tom Mikkelsen. (2011) Recurrent high-grade glioma: a diagnostic and therapeutic challenge. Expert Review of Neurotherapeutics 11:4, pages 509-518.
Read now
Read now
Dongsheng Guo, Baofeng Wang, Fuxin Han & Ting Lei. (2010) RNA interference therapy for glioblastoma. Expert Opinion on Biological Therapy 10:6, pages 927-936.
Read now
Read now
Articles from other publishers (29)
Heeyeon Cho & Jinkyung Kim. (2022) Effects of preschoolers’ self-esteem and executive function on social competence. Korean Journal of Human Ecology 31:6, pages 689-705.
Crossref
Crossref
Aswani P. Krishna, Sebastian John, Puja Laxmanrao Shinde & Rashmi Mishra. (2021) Proteo-transcriptomics meta-analysis identifies SUMO2 as a promising target in glioblastoma multiforme therapeutics. Cancer Cell International 21:1.
Crossref
Crossref
Kyeongmin Kim, Sungmin Lee, Hyunkoo Kang, Eunguk Shin, Hae Yu Kim, HyeSook Youn & BuHyun Youn. (2021) Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function. International Journal of Molecular Sciences 22:6, pages 2982.
Crossref
Crossref
Cheripelil Abraham Manju, Kottarapat Jeena, Ranjith Ramachandran, Maneesh Manohar, Anna Mathew Ambily, Koythatta Meethalveedu Sajesh, Genekehal Siddaramana Gowd, Krishnakumar Menon, Keechilat Pavithran, Ashok Pillai, Shantikumar V Nair & Manzoor Koyakutty. (2021) Intracranially injectable multi-siRNA nanomedicine for the inhibition of glioma stem cells. Neuro-Oncology Advances 3:1.
Crossref
Crossref
Krishnankutty Chandrika Sivakumar, Jin Haixiao, C. Benjamin Naman & T. P. Sajeevan. (2020)
Prospects of
multitarget
drug designing strategies by linking molecular docking and molecular dynamics to explore the
protein–ligand
recognition process
. Drug Development Research 81:6, pages 685-699.
Crossref
Crossref
Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai, Jan J. Melenhorst, Keith Mansfield, Jennifer J. D. Morrissette, Maria Martinez-Lage, Steven Brem, Eileen MaloneyAngela Shen, Randi Isaacs, Suyash MohanGabriela Plesa, Simon F. Lacey, Jean-Marc Navenot, Zhaohui Zheng, Bruce L. Levine, Hideho OkadaCarl H. June, Jennifer L. BrogdonMarcela V. Maus. (2017) A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science Translational Medicine 9:399.
Crossref
Crossref
Vinay K. PuduvalliRekha ChaudharySamuel G. McClugageJames Markert. (2017)
Beyond Alkylating Agents for Gliomas:
Quo Vadimus
?
. American Society of Clinical Oncology Educational Book:37, pages 175-186.
Crossref
Crossref
Yi-Ting Wang, Szu-Hua Pan, Chia-Feng Tsai, Ting-Chun Kuo, Yuan-Ling Hsu, Hsin-Yung Yen, Wai-Kok Choong, Hsin-Yi Wu, Yen-Chen Liao, Tse-Ming Hong, Ting-Yi Sung, Pan-Chyr Yang & Yu-Ju Chen. (2017) Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer. Scientific Reports 7:1.
Crossref
Crossref
Leonardo Barcelos de Paula, Fernando Lucas Primo & Antonio Claudio Tedesco. 2017. Imaging in Photodynamic Therapy. Imaging in Photodynamic Therapy
131
148
.
Savita JayaramManoj Kumar GuptaRajesh RajuPoonam GautamRavi Sirdeshmukh. (2016) Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma. OMICS: A Journal of Integrative Biology 20:12, pages 736-746.
Crossref
Crossref
Laura A. JohnsonJohn SchollerTakayuki OhkuriAkemi KosakaPrachi R. PatelShannon E. McGettiganArben K. NaceTzvete DentchevPramod ThekkatAndreas LoewAlina C. BoesteanuAlexandria P. CogdillTaylor ChenJoseph A. FraiettaChristopher C. KlossAvery D. PoseyJr.Jr., Boris EngelsReshma SinghTucker EzellNeeraja IdamakantiMelissa H. RamonesNa LiLi ZhouGabriela PlesaJohn T. SeykoraHideho OkadaCarl H. JuneJennifer L. BrogdonMarcela V. Maus. (2015) Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma. Science Translational Medicine 7:275.
Crossref
Crossref
Patrick-Denis St-Coeur, Mohamed Touaibia, Miroslava Cuperlovic-Culf & Pier Jr Morin. (2013) Leveraging Metabolomics to Assess the Next Generation of Temozolomide-based Therapeutic Approaches for Glioblastomas. Genomics, Proteomics & Bioinformatics 11:4, pages 199-206.
Crossref
Crossref
Supreet Agarwal, Maha S. Al-Keilani, Mohammad A. Y. Alqudah, Zita A. Sibenaller, Timothy C. Ryken & Mahfoud Assem. (2013) Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma. PLoS ONE 8:5, pages e62852.
Crossref
Crossref
Mahfoud AssemZita SibenallerSupreet AgarwalMaha S. Al-KeilaniMohammad A.Y. AlqudahTimothy C. Ryken. (2012) Enhancing Diagnosis, Prognosis, and Therapeutic Outcome Prediction of Gliomas Using Genomics. OMICS: A Journal of Integrative Biology 16:3, pages 113-122.
Crossref
Crossref
Sith Sathornsumetee & Jeremy N. Rich. 2012. Neuro-Oncology. Vol 104 HCN Series. Neuro-Oncology. Vol 104 HCN Series
255
278
.
Dominique Dorin-Semblat, Sophie Schmitt, Jean-Philippe Semblat, Audrey Sicard, Luc Reininger, Dean Goldring, Shelley Patterson, Neils Quashie, Debopam Chakrabarti, Laurent Meijer & Christian Doerig. (2011) Plasmodium falciparum NIMA-related kinase Pfnek-1: sex specificity and assessment of essentiality for the erythrocytic asexual cycle. Microbiology 157:10, pages 2785-2794.
Crossref
Crossref
Ingo K. Mellinghoff, Andrew B. Lassman & Patrick Y. Wen. (2011) Signal transduction inhibitors and antiangiogenic therapies for malignant glioma. Glia 59:8, pages 1205-1212.
Crossref
Crossref
Xudong Luan, Chunmei Gao, Nannan Zhang, Yuzong Chen, Qinsheng Sun, Chunyan Tan, Hongxia Liu, Yibao Jin & Yuyang Jiang. (2011) Exploration of acridine scaffold as a potentially interesting scaffold for discovering novel multi-target VEGFR-2 and Src kinase inhibitors. Bioorganic & Medicinal Chemistry 19:11, pages 3312-3319.
Crossref
Crossref
Cunlong Zhang, Chunyan Tan, Xuyu Zu, Xin Zhai, Feng Liu, Bizhu Chu, Xiaohua Ma, Yuzong Chen, Ping Gong & Yuyang Jiang. (2011) Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors. European Journal of Medicinal Chemistry 46:4, pages 1404-1414.
Crossref
Crossref
Feng Jin, Chao Gao, Lei Zhao, Hao Zhang, Hai-Tao Wang, Tong Shao, Shu-Ling Zhang, Yu-Jia Wei, Xiao-Bing Jiang, Yin-Pu Zhou & Hong-Yang Zhao. (2011) Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor. Brain Research 1368, pages 82-90.
Crossref
Crossref
Sith Sathornsumetee & David A. Reardon. 2011. Primary Central Nervous System Tumors. Primary Central Nervous System Tumors
195
232
.
Walter J. Lukiw & Frank Culicchia. 2011. Neurochemical Mechanisms in Disease. Neurochemical Mechanisms in Disease
799
821
.
Donald J. AbrahamRobertson Graeme. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
223
294
.
Xiao Hua Ma, Zhe Shi, Chunyan Tan, Yuyang Jiang, Mei Lin Go, Boon Chuan Low & Yu Zong Chen. (2010) In-Silico Approaches to Multi-target Drug Discovery. Pharmaceutical Research 27:5, pages 739-749.
Crossref
Crossref
Michal Grzmil & Brian A. Hemmings. (2010) Deregulated signalling networks in human brain tumours. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1804:3, pages 476-483.
Crossref
Crossref
Richard Morphy. (2009) Selectively Nonselective Kinase Inhibition: Striking the Right Balance. Journal of Medicinal Chemistry 53:4, pages 1413-1437.
Crossref
Crossref
Nikhil G. ThakerFang Zhang, Peter R. McDonald, Tong Ying Shun, John S. Lazo & Ian F. Pollack. (2010) Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic development. Neurosurgical Focus 28:1, pages E4.
Crossref
Crossref
Patrick Y Wen & Alba A Brandes. (2009) Treatment of recurrent high-grade gliomas. Current Opinion in Neurology 22:6, pages 657-664.
Crossref
Crossref
Keith Ashman & Elena López Villar. (2009) Phosphoproteomics and cancer research. Clinical and Translational Oncology 11:6, pages 356-362.
Crossref
Crossref